CHARLOTTE CLAW 3.5

K080295 · Wrightmedicaltechnologyinc · HRS · Feb 27, 2008 · Orthopedic

Device Facts

• Record ID: K080295
• Device Name: CHARLOTTE CLAW 3.5
• Applicant: Wrightmedicaltechnologyinc
• Product Code: HRS · Orthopedic
• Decision Date: Feb 27, 2008
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The CHARLOTTE™ CLAW® 3.5 is intended to be used for fixation such as: LisFranc arthrodesis, mono or bi-cortical osteotomies in the forefoot, first metatarsophalangeal arthrodesis, Akin osteotomy, midfoot and hindfoot arthrodeses or osteotomies, fixation of osteotomies for hallux valgus treatment (Scarf and Chevron), and arthrodesis of the metatarsocuneiform joint to reposition and stabilize metatarsus primus varus.

Device Story

The CHARLOTTE™ CLAW® 3.5 is a metallic bone fixation system consisting of curved 4-hole plates and locking screws. Used by orthopedic surgeons in clinical settings to provide stabilization and compression during foot and ankle reconstructive surgeries, including arthrodesis and osteotomies. The device functions as a mechanical implant to maintain bone alignment during the healing process, facilitating fusion or osteotomy stabilization. It is a passive implantable device; no software or electronic components are involved.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

System consists of curved 4-hole plates and locking screws of various lengths. Material: stainless steel. Mechanical fixation device.

Indications for Use

Indicated for patients requiring bone fixation in the forefoot, midfoot, and hindfoot, including procedures for LisFranc arthrodesis, osteotomies, metatarsophalangeal arthrodesis, Akin osteotomy, hallux valgus treatment (Scarf and Chevron), and metatarsocuneiform joint arthrodesis for metatarsus primus varus stabilization.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the word "WRIGHT" in large, bold, sans-serif font. Above the word, there is a handwritten number "KD 80295". Below the word "WRIGHT", there are three horizontal lines that are stacked on top of each other. The lines are thicker at the left and taper off to the right.

## 510(K) SUMMARY OF SAFETY AND EFFECTIVENESS

In accordance with the Food and Drug Administration Rule to implement provisions of the Safe Medical Devices Act of 1990 and in conformance with 21 CRF 807, this information serves as a Summary of Safety and Effectiveness for the use of the CHARLOTTE™ CLAW 3.5.

| Submitted By: | Wright Medical Technology, Inc. |
|-------------------------------------|--------------------------------------------------|
| Date: | January 23, 2005 |
| Contact Person: | Sarah Holtgrewe |
| | Regulatory Affairs Specialist |
| Proprietary Name: | CHARLOTTE™ CLAW 3.5 |
| Common Name: | Compression Plate |
| Classification Name and Reference: | 21 CFR 888.3030 Plate, Fixation, Bone – Class II |
| Device Product Code and Panel Code: | Orthopedics/87/HRS |

### DEVICE INFORMATION

#### A. INTENDED USE

The CHARLOTTE™ CLAW® 3.5 is intended to be used for fixation such as: LisFranc arthrodesis, mono or bi-cortical osteotomies in the forefoot, first metatarsophalangeal arthrodesis, Akin osteotomy, midfoot and hindfoot arthrodeses or osteotomies, fixation of osteotomies for hallux valgus treatment (Scarf and Chevron), and arthrodesis of the metatarsocuneiform joint to reposition and stabilize metatarsus primus varus.

#### B. DEVICE DESCRIPTION

The CHARLOTTE™ CLAW® 3.5 consists of curved 4-hole plates and locking screws of various lengths. All plates and screws are manufactured from stainless steel.

### C. SUBSTANTIAL EQUIVALENCE INFORMATION

The design features of the CHARLOTTE™ CLAW® 3.5 system are substantially equivalent to the design features of the predicates identified in this 510(k) submission. The safety and effectiveness of the CHARLOTTE™ CLAW® 3.5 is adequately supported by the substantial equivalence information, materials information, and analysis data provided within this premarket notification.

www.wmt.com

{1}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The eagle faces right. Encircling the eagle is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Public Health Service

FEB 2 7 2008

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Wright Medical Technology, Inc. % Ms. Sarah Holtgrewe Regulatory Affairs Specialist 5677 Airline Road Arlington, TN 38002

Re: K080295 Trade/Device Name: Charlotte™ Claw® 3.5 Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: HRS Dated: January 24, 2008 Received: February 4, 2008

Dear Ms. Holtgrewe:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{2}------------------------------------------------

#### Page 2 – Ms. Sarah Holtgrewe

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at [phone]. For questions regarding of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at [phone]. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number [phone] or [phone] or the Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Mark M. Millerson

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

# Indications for Use

510(k) Number (if known):

Device Name:_CHARLOTTE™ CLAW 3.5

Indications For Use:

The CHARLOTTE™ CLAW® 3.5 is intended to be used for fixation such as: LisFranc arthrodesis, mono or bi-cortical osteotomies in the forefoot, first metatarsophalangeal arthrodesis, Akin osteotomy, midfoot and hindfoot arthrodeses or osteotomies, fixation of osteotomies for hallux valgus treatment (Scarf and Chevron), and arthrodesis of the metatarsocuneiform joint to reposition and stabilize metatarsus primus varus.

Prescription Use XXX (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

1 of 1

Loubare Buchem

Division of General, Restorative. and Neurological Devices

**510(k) Number** K080295